NasdaqGS - Delayed Quote USD
Y-mAbs Therapeutics, Inc. (YMAB)
4.7100
+0.0800
+(1.73%)
At close: June 13 at 4:00:01 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 315,100 | 6 |
| Sales | 14,727 | 2 |
| Net Shares Purchased (Sold) | 300,373 | 8 |
| Total Insider Shares Held | 5.31M | -- |
| % Net Shares Purchased (Sold) | 6.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| GAD THOMAS Officer and Director | Conversion of Exercise of derivative security at price 2.00 per share. | Direct | 206,000 | Jun 3, 2025 |
| GAD THOMAS Officer and Director | Sale at price 5.23 per share. | Direct | 56,536 | Mar 7, 2025 |
| ROSSI MICHAEL J Chief Executive Officer | Sale at price 5.20 per share. | Direct | 20,368 | Mar 7, 2025 |
| PFREUNDSCHUH PETER P Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2025 |
| LAROCCA JOHN General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2025 |
| WILMS JORIS Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2025 |
| GAD THOMAS Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2025 |
| ROSSI MICHAEL J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2025 |
| GAD THOMAS Officer and Director | Conversion of Exercise of derivative security at price 4.38 per share. | Direct | 100,000 | Sep 19, 2024 |
| GAD THOMAS Officer and Director | Sale at price 12.97 - 13.47 per share. | Indirect | 1,264,650 | Sep 16, 2024 |
| LUND-HANSEN TORBEN Chief Technology Officer | Sale at price 15.37 per share. | Direct | 768,500 | Aug 28, 2024 |
| LUND-HANSEN TORBEN Chief Technology Officer | Conversion of Exercise of derivative security at price 4.38 per share. | Direct | 219,000 | Aug 28, 2024 |
| WILMS JORIS Chief Operating Officer | Sale at price 14.69 per share. | Direct | 73,450 | Aug 26, 2024 |
| PFREUNDSCHUH PETER P Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 12, 2024 |
| GAD THOMAS Officer and Director | Sale at price 12.00 - 12.03 per share. | Indirect | 841,050 | Jun 11, 2024 |
| GILL DAVID N. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| HEALY JAMES I Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| TAGLIAFERRI MARY ANN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| HAMILL LAURA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| TYAGI ASHUTOSH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| WEDELL-WEDELLSBORG JOHAN Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| BER GERARD Director | Sale at price 12.00 per share. | Direct | 8,664 | Jun 10, 2024 |
| KRUSE BO Chief Financial Officer | Sale at price 12.03 - 12.07 per share. | Direct | 723,055 | May 31, 2024 |
| KRUSE BO Chief Financial Officer | Conversion of Exercise of derivative security at price 2.00 per share. | Direct | 120,000 | May 31, 2024 |
| GAD THOMAS Officer and Director | Sale at price 12.00 - 13.00 per share. | Indirect | 395,563 | May 23, 2024 |
| TAGLIAFERRI MARY ANN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 12, 2024 |
| GAD THOMAS Officer and Director | Sale at price 16.44 per share. | Direct | 64,116 | Mar 5, 2024 |
| RAJAH VIGNESH Officer | Sale at price 16.53 per share. | Direct | 28,283 | Mar 5, 2024 |
| SMITH SUSAN LAURA Officer | Sale at price 16.55 per share. | Direct | 27,837 | Mar 5, 2024 |
| ROSSI MICHAEL J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| WILMS JORIS Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| KRUSE BO Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| GAD THOMAS Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| LUND-HANSEN TORBEN Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| LISBY STEEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| RAJAH VIGNESH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| SMITH SUSAN LAURA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| GAD THOMAS Officer and Director | Conversion of Exercise of derivative security at price 2.00 per share. | Direct | 100,000 | Dec 21, 2023 |
| GAD THOMAS Officer and Director | Sale at price 6.58 - 6.83 per share. | Indirect | 1,001,000 | Dec 15, 2023 |
| WEDELL-WEDELLSBORG JOHAN Director | Purchase at price 6.50 - 7.01 per share. | Indirect | 890,411 | Dec 11, 2023 |
| WEDELL-WEDELLSBORG JOHAN Director | Purchase at price 6.85 per share. | Indirect | 44,232 | Dec 11, 2023 |
| WG BIOTECH APS Director | Purchase at price 6.50 - 7.01 per share. | Direct | 890,411 | Dec 11, 2023 |
| WG BIOTECH APS Director | Purchase at price 6.85 per share. | Direct | 44,232 | Dec 11, 2023 |
| WEDELL-WEDELLSBORG JOHAN Director | Purchase at price 5.97 per share. | Indirect | 309,477 | Nov 29, 2023 |
| WG BIOTECH APS Director | Purchase at price 5.97 per share. | Direct | 309,477 | Nov 29, 2023 |
| WEDELL-WEDELLSBORG JOHAN Director | Purchase at price 5.49 - 5.81 per share. | Indirect | 521,294 | Nov 28, 2023 |
| WG BIOTECH APS Unknown | Purchase at price 5.49 - 5.81 per share. | Direct | 521,294 | Nov 28, 2023 |
| GAD THOMAS Officer and Director | Sale at price 5.30 - 5.31 per share. | Indirect | 795,382 | Nov 21, 2023 |
Related Tickers
STOK Stoke Therapeutics, Inc.
11.53
-2.45%
REPL Replimune Group, Inc.
9.78
-1.06%
CRNX Crinetics Pharmaceuticals, Inc.
31.77
-1.24%
ALEC Alector, Inc.
1.5400
-4.94%
SRRK Scholar Rock Holding Corporation
32.45
-2.61%
ORIC ORIC Pharmaceuticals, Inc.
9.63
-0.41%
ANAB AnaptysBio, Inc.
23.32
-0.38%
PASG Passage Bio, Inc.
0.3910
-9.43%
STRO Sutro Biopharma, Inc.
0.7991
-1.50%
IGMS IGM Biosciences, Inc.
1.2100
0.00%